Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
International Journal of Cardiology|January 31, 2016
Three-year follow-up outcomes of SES and PES in a randomized controlled study stratified by the presence of diabetes mellitus: J-DEsSERT trialMasato Nakamura, Toshiya Muramatsu, Hiroyoshi Yokoi, et al.
Journal of the American Heart Association|September 2, 2017
Clinical Outcomes of Deferred Lesions With Angiographically Insignificant Stenosis But Low Fractional Flow ReserveJoo Myung Lee, Bon-Kwon Koo, Eun-Seok Shin, et al.
Circulation. Cardiovascular Interventions|July 8, 2026
Optical Coherence Tomography Characterization of Coronary Lithotripsy Following Atherectomy for Treatment of Severely Calcified LesionsYohei Sotomi, Nehiro Kuriyama, Yutaka Tanaka, et al.
Circulation Reports|February 12, 2024
Sex Differences in 5-Year Outcomes After Deferral of Revascularization Following Physiological Coronary AssessmentTakayuki Ishihara, Shoichi Kuramitsu, Hitoshi Matsuo, et al.
European Heart Journal|October 12, 2017
Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery diseaseJoo Myung Lee, Bon-Kwon Koo, Eun-Seok Shin, et al.
JACC. Cardiovascular Interventions|February 25, 2022
Thrombotic Risk and Cardiovascular Events in Patients With Revascularization Deferral After Fractional Flow Reserve AssessmentYasutsugu Shiono, Shoichi Kuramitsu, Hitoshi Matsuo, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 9, 2020
Monotherapy With Prasugrel After Dual-Antiplatelet Therapy for Japanese Percutaneous Coronary Intervention Patients With High Bleeding Risk - A Prospective Cohort Study (PENDULUM mono Study)Masato Nakamura, Yoshihiro Morino, Tsunekazu Kakuta, et al.
JACC. Cardiovascular Interventions|June 24, 2017
Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent ImplantationMasato Nakamura, Raisuke Iijima, Junya Ako, et al.
Pageof 23